Our story has never been only about making medicines, but also about making a difference in the lives of the patients we serve.
Cipla – established in 1935 – is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets.
Manufacturing excellence – Made in Africa, for Africa
Cipla is committed to making the highest quality, affordable, life-saving medicines because we want people to live a long and healthy life. We see a future where good health is expected – not for the few but for the many. That’s why we believe no-one should be denied access to essential medicine. We’re not just about making medicine, we’re about making a difference.
Cipla’s goal is to produce pharmaceutical products of the highest quality that have minimal environmental impact, adhere strictly to Good Manufacturing Practices (cGMP) and Good Laboratory Practices (GLP), and numerous other international regulatory standards at our WHO-compliant facility. Cipla continually strives to produce quality, affordable medicines that will meet the demands of the increasing African population.